Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target.
Barabé F, Gil L, Celton M, Bergeron A, Lamontagne V, Roques É, Lagacé K, Forest A, Johnson R, Pécheux L, Simard J, Pelloux J, Bellemare-Pelletier A, Gagnon E, Hébert J, Cellot S, Wilhelm BT.
Barabé F, et al. Among authors: gagnon e.
Leukemia. 2017 May;31(5):1166-1176. doi: 10.1038/leu.2016.302. Epub 2016 Oct 26.
Leukemia. 2017.
PMID: 27780967